Form 8-K - Current report:
SEC Accession No. 0001213900-25-052635
Filing Date
2025-06-09
Accepted
2025-06-09 16:21:42
Documents
16
Period of Report
2025-06-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0245171-8k_aditxt.htm   iXBRL 8-K 53538
2 UNSECURED PROMISSORY NOTE DATED JUNE 5, 2025 ea024517101ex10-1_aditxt.htm EX-10.1 13074
3 TRANSCRIPT OF WEEKLY UPDATE - JUNE 6, 2025 ea024517101ex99-1_aditxt.htm EX-99.1 44846
4 PRESS RELEASE DATED JUNE 9, 2025 ea024517101ex99-2_aditxt.htm EX-99.2 13302
5 GRAPHIC ex99-2_001.jpg GRAPHIC 5415
  Complete submission text file 0001213900-25-052635.txt   331844

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adtx-20250605.xsd EX-101.SCH 3008
7 XBRL LABEL FILE adtx-20250605_lab.xml EX-101.LAB 34239
8 XBRL PRESENTATION FILE adtx-20250605_pre.xml EX-101.PRE 22354
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0245171-8k_aditxt_htm.xml XML 3784
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 251034404
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)